Characteristic | HBcAb-negative [cases (%)] | HBcAb-positive [cases (%)] | P value |
---|---|---|---|
Total | 110 | 55 | Â |
Sex | Â | Â | 0.434 |
 Male | 67 (60.9) | 30 (54.5) | |
 Female | 43 (39.1) | 25 (45.5) | |
ECOG PS | Â | Â | 0.525 |
 0–1 | 96 (87.3) | 46 (83.6) | |
 ≥2 | 14 (12.7) | 9 (16.4) | |
Bulky mass | Â | Â | 0.619 |
 Yes | 28 (25.5) | 16 (29.1) | |
 No | 82 (74.5) | 39 (70.9) | |
B symptoms | Â | Â | 0.448 |
 − | 80 (72.7) | 43 (78.2) | |
 + | 30 (27.3) | 12 (21.8) | |
Ann Arbor stage†|  |  | 0.698 |
 I–II | 52 (47.3) | 28 (50.9) | |
 III-IV | 57 (51.8) | 27 (49.1) | |
Liver involvement | Â | Â | 0.720 |
 − | 104 (94.5) | 53 (96.4) | |
 + | 6 (5.5) | 2 (3.6) | |
IPI score†|  |  | 0.851 |
 0–1 | 48 (43.6) | 21 (38.2) | |
 2 | 28 (25.4) | 17 (30.9) | |
 3 | 23 (20.9) | 11 (20.0) | |
 4-5 | 10 (9.1) | 6 (10.9) | |
ALT | Â | Â | 0.874 |
 ≤40 U/L | 95 (86.4) | 47 (85.5) | |
 >40 U/L | 15 (13.6) | 8 (14.5) | |
AST | Â | Â | 0.863 |
 ≤45 U/L | 97 (88.2) | 49 (89.1) | |
 >45 U/L | 13 (11.8) | 6 (10.9) | |
TB | Â | Â | 0.852 |
 ≤20.5 μmol/L | 99 (90.0) | 50 (90.9) | |
 >20.5 μmol/L | 11 (10.0) | 5 (9.1) | |
LDH | Â | Â | 0.910 |
 ≤245 U/mL | 67 (60.9) | 33 (60.0) | |
 >245 U/mL | 43 (39.1) | 22 (40.0) | |
HBsAb | Â | Â | <0.001 |
 – | 82 (74.5) | 3 (5.5) | |
 + | 28 (25.5) | 52 (94.5) | |
HBeAb | Â | Â | 0.251 |
 – | 102 (92.7) | 48 (87.3) | |
 + | 8 (7.3) | 7 (12.7) |